Posts Tagged ‘patent expiration’

Patent delisted for NOVO drug FIASP

Annual Drug Patent Expirations for FIASP Fiasp is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents protecting…
The post Patent delisted for NOVO drug FIASP appeared first on DrugPatentWat…


Patent delisted for NOVO drug FIASP FLEXTOUCH

Annual Drug Patent Expirations for FIASP+FLEXTOUCH Fiasp Flextouch is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post Patent delisted for NOVO drug FIASP FLEXTOUCH appeared fir…


New patent expiration for Pfizer drug EXUBERA

Annual Drug Patent Expirations for EXUBERA Exubera is a drug marketed by Pfizer and is included in one NDA. There are three patents protecting this drug. This drug has three…
The post New patent expiration for Pfizer drug EXUBERA appeared first on Drug…


New patent expiration for Astrazeneca Pharms drug EPANOVA

Annual Drug Patent Expirations for EPANOVA Epanova is a drug marketed by Astrazeneca Pharms and is included in one NDA. There are nine patents protecting this drug. This drug has…
The post New patent expiration for Astrazeneca Pharms drug EPANOVA appea…


New patent expiration for Astrazeneca Pharms drug PULMICORT RESPULES

Annual Drug Patent Expirations for PULMICORT+RESPULES Pulmicort Respules is a drug marketed by Astrazeneca Pharms and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Astrazeneca Pharms drug…


New patent expiration for Pfizer drug TOVIAZ

Annual Drug Patent Expirations for TOVIAZ Toviaz is a drug marketed by Pfizer and is included in one NDA. It is available from four suppliers. There are eight patents protecting…
The post New patent expiration for Pfizer drug TOVIAZ appeared first on D…


New patent expiration for Astrazeneca drug SYMBICORT

Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting…
The post New patent expiration for Astrazeneca drug SYMBICOR…


New patent expiration for Astrazeneca Pharms drug PRILOSEC

Annual Drug Patent Expirations for PRILOSEC Prilosec is a drug marketed by Astrazeneca Pharms and Covis Pharma Bv and is included in three NDAs. It is available from three suppliers.…
The post New patent expiration for Astrazeneca Pharms drug PRILOSEC …


New patent expiration for Janssen Pharms drug INVEGA SUSTENNA

Annual Drug Patent Expirations for INVEGA+SUSTENNA Invega Sustenna is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Janssen Pharms drug INVEGA SUSTENNA…


Drug Patent Expirations for the Week of May 5, 2019

MEMBRANEBLUE (trypan blue) Dorc Patent: 6,696,430 Expiration: May 7, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Patent E…


Do NOT follow this link or you will be banned from the site!